

(Alliance News) - European blue-chips opened in the green on Wednesday, after US stocks retreated on Tuesday ahead of US President Donald Trump's tari...


(Alliance News) - ImmuPharma PLC on Monday said its core anti-infective programme with antifungal and antibacterial candidates is progressing through ...


(Alliance News) - ImmuPharma PLC on Thursday announced "new discoveries" regarding the mechanism of action of its P140 autoimmune technology platform.


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.


ImmuPharma PLC - London-based specialist drug discovery and development company - Notes recent movements in its share price, as it has more than multi...


(Sharecast News) - Specialist drug discovery and development outfit ImmuPharma has said that it can't pinpoint a reason behind its share price more th...


ImmuPharma PLC - London-based specialist drug discovery and development company - Says its preclinical research program focused on P140 and the pathog...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.